What is the role of NGS for identifying “HER-2 enrichment” therapy? What is the situation in Asia as far deploying NGS in patients with breast cancer?

What is the role of NGS for identifying “HER-2 enrichment” therapy? What is the situation in Asia as far deploying NGS in patients with breast cancer?

What is the role of NGS for identifying “HER-2 enrichment” therapy? What is the situation in Asia as far deploying NGS in patients with breast cancer?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Janice Tsang, MBBS, MRCP(UK), FRCP (Lond.)

Janice Tsang, MBBS, MRCP(UK), FRCP (Lond.)

Specialist in Medical Oncology
Hon. Clinical Assistant Professor
Li Ka Sing Faculty of Medicine
The University of Hong Kong